 Participants in study C-1073-400 NCT00569582 will be invited to participate in this extension study to examine the long term safety of mifepristone in the treatment of the signs and symptoms of endogenous Cushings syndrome. Total treatment duration may be up to 12 months or longer at the discretion of the Investigator. 